» Articles » PMID: 26458166

Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2015 Oct 13
PMID 26458166
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the mode of action underlying lytic inactivation of HIV-1 virions by peptide triazole thiol (PTT), in particular the relationship between gp120 disulfides and the C-terminal cysteine-SH required for virolysis. Obligate PTT dimer obtained by PTT SH cross-linking and PTTs with serially truncated linkers between pharmacophore isoleucine-ferrocenyltriazole-proline-tryptophan and cysteine-SH were synthesized. PTT variants showed loss of lytic activity but not binding and infection inhibition upon SH blockade. A disproportionate loss of lysis activity vs binding and infection inhibition was observed upon linker truncation. Molecular docking of PTT onto gp120 argued that, with sufficient linker length, the peptide SH could approach and disrupt several alternative gp120 disulfides. Inhibition of lysis by gp120 mAb 2G12, which binds at the base of the V3 loop, as well as disulfide mutational effects, argued that PTT-induced disruption of the gp120 disulfide cluster at the base of the V3 loop is an important step in lytic inactivation of HIV-1. Further, PTT-induced lysis was enhanced after treating virus with reducing agents dithiothreitol and tris (2-carboxyethyl)phosphine. Overall, the results are consistent with the view that the binding of PTT positions the peptide SH group to interfere with conserved disulfides clustered proximal to the CD4 binding site in gp120, leading to disulfide exchange in gp120 and possibly gp41, rearrangement of the Env spike, and ultimately disruption of the viral membrane. The dependence of lysis activity on thiol-disulfide interaction may be related to intrinsic disulfide exchange susceptibility in gp120 that has been reported previously to play a role in HIV-1 cell infection.

Citing Articles

Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.

Nangarlia A, Hassen F, Canziani G, Bandi P, Talukder C, Zhang F Biochemistry. 2023; 62(14):2115-2127.

PMID: 37341186 PMC: 10663058. DOI: 10.1021/acs.biochem.3c00109.


Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability.

Carter E, Ang C, Chaiken I Curr Protein Pept Sci. 2022; 24(1):59-77.

PMID: 35692162 PMC: 11660822. DOI: 10.2174/1389203723666220610120927.


Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.

Zhang S, Holmes A, Dick A, Rashad A, Enriquez Rodriguez L, Canziani G Retrovirology. 2021; 18(1):31.

PMID: 34627310 PMC: 8501640. DOI: 10.1186/s12977-021-00575-z.


Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Ang C, Carter E, Haftl A, Zhang S, Rashad A, Kutzler M Microorganisms. 2021; 9(6).

PMID: 34204725 PMC: 8231586. DOI: 10.3390/microorganisms9061286.


HIV-1 Env-Dependent Cell Killing by Bifunctional Small-Molecule/Peptide Conjugates.

Gaffney A, Nangarlia A, Ang C, Gossert S, Rashad Ahmed A, Hossain M ACS Chem Biol. 2021; 16(1):193-204.

PMID: 33410670 PMC: 8218882. DOI: 10.1021/acschembio.0c00888.


References
1.
Biorn A, Cocklin S, Madani N, Si Z, Ivanovic T, Samanen J . Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. Biochemistry. 2004; 43(7):1928-38. DOI: 10.1021/bi035088i. View

2.
Aneja R, Rashad A, Li H, Sundaram R, Duffy C, Bailey L . Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120. J Med Chem. 2015; 58(9):3843-58. PMC: 4497506. DOI: 10.1021/acs.jmedchem.5b00073. View

3.
Chen L, Kwon Y, Zhou T, Wu X, ODell S, Cavacini L . Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science. 2009; 326(5956):1123-7. PMC: 2862588. DOI: 10.1126/science.1175868. View

4.
Cerutti N, Mendelow B, Napier G, Papathanasopoulos M, Killick M, Khati M . Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange. J Biol Chem. 2010; 285(33):25743-52. PMC: 2919137. DOI: 10.1074/jbc.M110.144121. View

5.
McFadden K, Fletcher P, Rossi F, Kantharaju , Umashankara M, Pirrone V . Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitors. Antimicrob Agents Chemother. 2011; 56(2):1073-80. PMC: 3264272. DOI: 10.1128/AAC.05555-11. View